MPA Pharma GmbH
ent_01a02d99366036b32dbf15fee9afe140
Disclosures
2
Leak Site · 1 jurisdiction
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
2
unverified actor claims
Identity resolution
- Canonical name
- MPA Pharma GmbH
- Normalized
- mpa pharma— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 5299008B5QF40PQZZ082
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- mpapharma.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (2)newest first
- GLOBALLeak Siteas victim2026-09-18
MPA Pharma MPA Pharma GmbH is an internationally active, rapidly growing company specializing in the import and trade of high-quality pharmaceuticals, including both patented and generic products. 2,899,290 files, ~5.8 TBPharmaceutical companyCategories: accounting records and database backups, government audits (customs / corporate tax / social security / wage tax),corporate ownership (nominee structure, beneficial-ownership filings, related-party payments), narcotics/BtM records (opioids, cannabis, precursors),litigation files, executive and employee personal data, IT artifacts, pharmacovigilance correspondence.Credit cards with CVV of executives, Oltersdorf ID card valid until 2030, the Pfeiffer letter on the hidden Paranova Pack B.V., UBO passportsSQL backups (17.7 million general-ledger rows), commercial register extract (HRB), organizational chartCredentials (TIER 1) - a list of all password files (values not repeated here, stored in the MPA PASSWORDS report)Government audits - customs 17,011.77 EUR with a breakdown, corporate tax +202,203.18 EUR, social security (DRV) 23,134.96 EUR with a separate case against the managing director, wage-tax auditNarcotics (BtM) - permits (318 04 74), reconciliations of 588 rows / 93 differences, fentanyl, hydromorphone, oxycodone, tapentadol, unexplained remainders of 1-13 units, documentation gap 2017-2020, cannabis up to 22 percent THC, precursorsLitigation - MSD/Merck memo, settlement agreement, Amgros judgment 5,180,043.09 DKK, complaint to the Ministry of Health, arbitration filingPeople, security, pharmacovigilance, bulk financial recordsArtifacts - leadership phone book, employee medical documents, Eli Lilly 2025, AstraZeneca, rebate contracts, a list of all produced reports More
- GLOBALLeak Siteas victim2026-08-23
MPA Pharma GmbH is an internationally active, rapidly growing company specializing in the import and trade of high-quality pharmaceuticals, including both patented and generic products. With over 35 years of expertise in the pharmaceutical market, they also provide contract manufacturing services for third parties. Their primary clients include pharmacies and businesses in need of reliable pharmaceutical and medical products. Revenue $614 Million